ReviewInternational journal of molecular sciences2022

Enhancing the Therapeutic Potential of Mesenchymal Stromal Cell-Based Therapies with an Anti-Fibrotic Agent for the Treatment of Chronic Kidney Disease.

Yifang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.